Skip to main content
. 2019 Mar 7;2019:2835152. doi: 10.1155/2019/2835152

Table 6.

Effect of Adansonia digitales leaf extract on blood cell count, glycosylated hemoglobin, and erythropoietin of diabetic rats.

Parameters Groups
Normal control Diabetic control Diabetic + Leaf extract Diabetic + GBC 0.5 mg/Kg
200 mg/kg 400 mg/kg
RBCs count (x106/ml) 7.50±0.46 4.00 ±0.25N 4.70±0.11N@ 5.33±0.25N@ 6.11 ±0.16N

WBCs count (x105/ml) 5.40 ±0.23 12.50±0.65N 9.76±0.47N@ 8.00±0.41N 7.65±0.58N

Hb level (g/dl) 16.00±1.04 11.85±0.49N 12.50±0.23N@ 14.78±0.54N 14.90±0.36N

PCV (%) 50.00±2.96 35.19±1.28N 44.00±2.18N@ 53.39±3.21 54.00±3.25

GHb (%) 4.56±0.07 13.00±0.48N 8.60 ±0.54N@ 7.00±0.16N 7.50±0.68N

EPO (ng/ml) 2.78±0.04 0.58±0.01N 1.34±0.05N@ 1.86±0.03N@ 2.20±0.06N

All the data has been expressed as mean ± SEM of eight independent samples from each group (n = 8) analyzed by SPSS 13.0 version. The treated groups are CN (control normal), DM (diabetic or group II). DM+E200: diabetic rats treated with 200mg/Kg of leaf extract (group III); DM+E400: diabetic rats treated with 400mg/Kg of leaf extract; DM+GBC (group IV): diabetic rats treated with glibenclamide (group V).

N: significant difference from normal control.

: significant difference from positive control (untreated diabetic).

@: significant difference from the reference drug, glibenclamide.

GBC: glibenclamide; GHb: glycosylated hemoglobin; EPO: Erythropoietin.